Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 7Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia 3Hodgkin Disease 3Melanoma 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Dexamethasone 17Melphalan 14Bortezomib 10Calcium Dobesilate 8Filgrastim 6Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 5birtamimab 4dexamethasone acetate 3Whole-Body Irradiation 3Thalidomide 3Peripheral Blood Stem Cell Transplantation 3Lenalidomide 3fludarabine phosphate 2daratumumab 2Mycophenolic Acid 2Etoposide 2Doxycycline 2Darbepoetin alfa 2Cyclosporine 2Busulfan 2Blood Component Removal 2pomalidomide 1pegfilgrastim 1ixazomib 1isatuximab 1ferrous sulfate 1ferric gluconate 1dexamethasone 21-phosphate 1carfilzomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Immunoglobulin Light-chain Amyloidosis × Blood Component Removal × Clear all
NCT00651937 2020-01-14

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 7 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT02489500 2018-09-10

VelRand

Boston Medical Center

Phase 3 Terminated
3 enrolled 11 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡